| Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer M Robinson, A Sabbagh, R Muirhead, L Durrant, F Van den Heuvel, ... Radiotherapy and Oncology 117 (2), 246-251, 2015 | 19 | 2015 |
| Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer DLP Holyoake, M Robinson, D Grose, D McIntosh, D Sebag-Montefiore, ... Radiotherapy and Oncology 121 (1), 86-91, 2016 | 15 | 2016 |
| Intensity-modulated radiotherapy for rectal cancer in the UK in 2020 CR Hanna, F Slevin, A Appelt, M Beavon, R Adams, C Arthur, M Beasley, ... Clinical Oncology 33 (4), 214-223, 2021 | 14 | 2021 |
| Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer M Robinson, R Muirhead, C Jacobs, R Cooke, KY Chu, F Van den Heuvel, ... Radiotherapy and Oncology 143, 19-23, 2020 | 14 | 2020 |
| SPARC, a phase-I trial of pre‐operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer DLP Holyoake, M Robinson, M Silva, D Grose, D McIntosh, ... Radiotherapy and Oncology 155, 278-284, 2021 | 13 | 2021 |
| Stereotactic body radiation therapy reirradiation for locally recurrent rectal cancer: Outcomes and toxicity T Smith, SM O’Cathail, S Silverman, M Robinson, Y Tsang, M Harrison, ... Advances in radiation oncology 5 (6), 1311-1319, 2020 | 13 | 2020 |
| Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes R Cooke, P Camilleri, KY Chu, SM O'Cathail, M Robinson, ... Technical innovations & patient support in radiation oncology 13, 24-30, 2020 | 10 | 2020 |
| Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT) L Durrant, M Robinson, MA Hawkins, F Van den Heuvel, R Muirhead Radiotherapy and Oncology 121 (1), 92-97, 2016 | 6 | 2016 |
| High quality clinical stereotactic radiosurgery planning and delivery with standard resolution (5 mm) multileaf collimation and multiple isocenters M Robinson, C Tunstall, F Van den Heuvel, C Hobbs, S Padmanaban Practical Radiation Oncology 10 (4), 293-300, 2020 | 5 | 2020 |
| Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer M Robinson, S O'Cathail, A Duffton, K Aitken, R Muirhead Clinical Oncology, 2022 | 4 | 2022 |
| Oral contrast improves soft tissue matching in image guided radiation therapy for gastrointestinal (GI) tumors KY Chu, CL Eccles, T Baker, L Durrant, D Holyoake, M Robinson, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), E170-E171, 2016 | 4 | 2016 |
| Role of the Neuroradiologist and Neurosurgeon in Contouring with the Clinical Oncologist for Stereotactic Radiosurgery M Robinson, K Sayal, C Tunstall, S Padmanaban, R Watson, P Pretorius, ... Clinical Oncology 34 (6), 398-406, 2022 | 2 | 2022 |
| PO-1677 Planning feasibility study of three and single fraction Pancreas MR-Linac SBRT-Phase 1 trial setup K Chu, S Teoh, T Maughan, M Robinson, J Drabble, T Whyntie, ... Radiotherapy and Oncology 170, S1476-S1477, 2022 | 2 | 2022 |
| Analysis of on-trial quality assurance for the SPARC Clinical Trial using novel peer-review methodology D Holyoake, M Robinson, D Grose, D McIntosh, G Radhakrishna, ... Clinical Oncology 30 (6), e60, 2018 | 2 | 2018 |
| Conformity analysis of target volumes for Margin-Intense Radiotherapy in Borderline-Resectable Pancreatic Cancer DLP Holyoake, M Robinson, D Grose, D McIntosh, D Sebag-Montefiore, ... Clinician 1 (6.4), 1.2, 0 | 2* | |
| Automated scripting of the dosimetric evaluation of adaptive versus non-adaptive radiotherapy P Samant, B George, T Whyntie, M Robinson Biomedical Physics & Engineering Express 8 (3), 037001, 2022 | 1 | 2022 |
| Treatment planning of dose escalation for anal cancer in the PLATO trial NL Abbott, D Christophides, M Robinson, J Copeland, R Adams, ... Elsevier, 2017 | 1 | 2017 |
| Personalized dose escalation in anal cancer M Robinson, D Christophides, R Cooper, P Murray, J Lilley, R Muirhead, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), E198, 2016 | 1 | 2016 |
| Modelling of Dosimetric Impact of Visceral Organ Variability During MRI-Guided Hypofractionated Stereotactic Ablative Radiotherapy (SABR) to the Pancreas S Teoh, KY Chu, M Robinson, T Whyntie, F Van Den Heuvel, S Mukherjee, ... International Journal of Radiation Oncology, Biology, Physics 111 (3), e556-e557, 2021 | | 2021 |
| P14. 85 Impact of the neuro-radiologist and neuro-surgeon in contouring with the neuro-oncologist on local relapse rates for brain metastases treated with stereotactic radiosurgery M Robinson, K Sayal, C Tunstall, S Padmanaban, R Watson, P Pretorius, ... Neuro-Oncology 23 (Supplement_2), ii54-ii54, 2021 | | 2021 |
